Canopy Growth Corp (TSE:WEED – Get Free Report)’s stock price fell 0.7% during mid-day trading on Tuesday . The stock traded as low as C$1.36 and last traded at C$1.36. 319,863 shares were traded during mid-day trading, a decline of 84% from the average session volume of 1,958,357 shares. The stock had previously closed at C$1.37.
Analyst Ratings Changes
A number of brokerages have weighed in on WEED. ATB Cormark Capital Markets raised Canopy Growth from a “sector perform” rating to an “outperform” rating and set a C$1.40 price target on the stock in a research report on Tuesday, March 17th. Alliance Global Partners decreased their target price on Canopy Growth from C$1.80 to C$1.60 in a report on Tuesday, June 16th. Finally, Canaccord Genuity Group set a C$2.00 price target on Canopy Growth and gave the company a “speculative buy” rating in a research note on Friday, March 27th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of C$1.88.
View Our Latest Stock Report on WEED
Canopy Growth Trading Down 0.7%
Canopy Growth (TSE:WEED – Get Free Report) last announced its earnings results on Monday, June 15th. The company reported C($0.40) earnings per share for the quarter. Canopy Growth had a negative return on equity of 35.48% and a negative net margin of 84.76%.The firm had revenue of C$71.25 million for the quarter. On average, analysts forecast that Canopy Growth Corp will post -0.69 earnings per share for the current year.
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.
Featured Articles
- Five stocks we like better than Canopy Growth
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.
